Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Milone

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Immunity|February 18, 2016
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Cancer Immunology Research|July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T CellsSaba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Nature Biotechnology|November 14, 2024
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Nature Immunology|June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domainsCaitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Immunity|February 18, 2016
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Cancer Immunology Research|July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T CellsSaba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Nature Biotechnology|November 14, 2024
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Nature Immunology|June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domainsCaitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
Pageof 11